Follistatin-Like 1 Is Downregulated in Morbidly and Super Obese Central-European Population
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
30595761
PubMed Central
PMC6282119
DOI
10.1155/2018/4140815
Knihovny.cz E-zdroje
- MeSH
- 3' nepřekládaná oblast MeSH
- adipogeneze genetika MeSH
- běloši MeSH
- biologické markery krev MeSH
- dospělí MeSH
- down regulace MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA metabolismus MeSH
- mladiství MeSH
- morbidní obezita krev genetika MeSH
- obezita krev genetika MeSH
- proteiny související s folistatinem krev genetika MeSH
- senioři MeSH
- vazebná místa MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- 3' nepřekládaná oblast MeSH
- biologické markery MeSH
- FSTL1 protein, human MeSH Prohlížeč
- mikro RNA MeSH
- proteiny související s folistatinem MeSH
Follistatin-like 1 (FSTL1) is a secreted adipomyokine with a possible link to obesity; however, its connection to extreme obesity currently remains unknown. In order to analyze such association for the very first time, we employed a unique cohort of morbidly and super obese individuals with a mean BMI of 44.77 kg/m2 and measured the levels of circulating FSTL1. We explored the 3' UTR of FSTL1 to locate a genetic variant which impairs microRNA binding. We located and investigated such SNP (rs1057231) in relation to the FSTL1 protein level, obesity status, and other body composition parameters. We observed a significant decline in FSTL1 level in obese subjects in comparison to nonobese ones. The evaluated SNP was found to correlate with FSTL1 only in nonobese subjects. The presented results were not affected by sex since both males and females expressed FSTL1 equally. We suggest that the FSTL1 decrease observed in extremely obese subjects is a result of adipogenesis reduction accompanied by a senescence of preadipocytes which otherwise willingly express FSTL1, increased adipocyte apoptosis, and epigenetic FSTL1 silencing.
Zobrazit více v PubMed
Fasshauer M., Blüher M. Adipokines in health and disease. Trends in Pharmacological Sciences. 2015;36(7):461–470. doi: 10.1016/j.tips.2015.04.014. PubMed DOI
Arslan N., Erdur B., Aydin A. Hormones and cytokines in childhood obesity. Indian Pediatrics. 2010;47(10):829–839. doi: 10.1007/s13312-010-0142-y. PubMed DOI
Vegiopoulos A., Rohm M., Herzig S. Adipose tissue: between the extremes. EMBO Journal. 2017;36(14):1999–2017. doi: 10.15252/embj.201696206. PubMed DOI PMC
SHIBANUMA M., MASHIMO J.'., MITA A., KUROKI T., NOSE K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. European Journal of Biochemistry. 1993;217(1):13–19. doi: 10.1111/j.1432-1033.1993.tb18212.x. PubMed DOI
Fan N., Sun H., Wang Y., et al. Follistatin-like 1: a potential mediator of inflammation in obesity. Mediators of Inflammation. 2013;2013:12. doi: 10.1155/2013/752519.752519 PubMed DOI PMC
Lehr S., Hartwig S., Lamers D., et al. Identification and validation of novel adipokines released from primary human adipocytes. Molecular & Cellular Proteomics. 2012;11(1, article M111.010504) doi: 10.1074/mcp.M111.010504. PubMed DOI PMC
Bartel D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi: 10.1016/S0092-8674(04)00045-5. PubMed DOI
Cruz K. J. C., de Oliveira A. R. S., Morais J. B. S., Severo J. S., Marreiro, PhD D. N. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity. Nutrition. 2017;35:28–35. doi: 10.1016/j.nut.2016.10.003. PubMed DOI
GEORGES M., CLOP A., MARCQ F., et al. Polymorphic microRNA-target interactions: a novel source of phenotypic variation. Cold Spring Harbor Symposia on Quantitative Biology. 2006;71:343–350. doi: 10.1101/sqb.2006.71.056. PubMed DOI
Bienertova-Vasku J., Bienert P., Tomandl J., et al. No association of defined variability in leptin, leptin receptor, adiponectin, proopiomelanocortin and ghrelin gene with food preferences in the Czech population. Nutritional Neuroscience. 2013;11(1):2–8. doi: 10.1179/147683008X301379. PubMed DOI
Ma Y., Bertone E. R., Stanek EJ 3rd, et al. Association between eating patterns and obesity in a free-living US adult population. American Journal of Epidemiology. 2003;158(1):85–92. doi: 10.1093/aje/kwg117. PubMed DOI
Gong J., Tong Y., Zhang H.-M., et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Human Mutation. 2012;33(1):254–263. doi: 10.1002/humu.21641. PubMed DOI
Yang W.-S., Hsiung C. A., Ho L.-T., et al. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia. 2003;46(7):977–983. doi: 10.1007/s00125-003-1136-2. PubMed DOI
Team R. C. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. http://www.R-project.org/
Oelsner K. T., Guo Y., To S. B. C., Non A. L., Barkin S. L. Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity. BMC Genomics. 2017;18(1):p. 57. doi: 10.1186/s12864-016-3473-9. PubMed DOI PMC
Wu Y., Zhou S., Smas C. M. Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion. Mechanisms of Development. 2010;127(3-4):183–202. doi: 10.1016/j.mod.2009.12.003. PubMed DOI PMC
Comuzzie A. G., Cole S. A., Laston S. L., et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012;7(12, article e51954) doi: 10.1371/journal.pone.0051954. PubMed DOI PMC
Miyamae T., Marinov A. D., Sowders D., et al. Follistatin-like protein-1 is a novel proinflammatory molecule. The Journal of Immunology. 2006;177(7):4758–4762. doi: 10.4049/jimmunol.177.7.4758. PubMed DOI
Oshima Y., Ouchi N., Sato K., Izumiya Y., Pimentel D. R., Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008;117(24):3099–3108. doi: 10.1161/CIRCULATIONAHA.108.767673. PubMed DOI PMC
Soukas A., Socci N. D., Saatkamp B. D., Novelli S., Friedman J. M. Distinct transcriptional profiles of adipogenesis in vivo and in vitro . The Journal of Biological Chemistry. 2001;276(36):34167–34174. doi: 10.1074/jbc.M104421200. PubMed DOI
Lessard J., Tchernof A. Depot- and obesity-related differences in adipogenesis. Clinical Lipidology. 2012;7(5):587–596. doi: 10.2217/clp.12.49. DOI
Liu J. F., Li Y. S., Drew P. A., Zhang C. The effect of celecoxib on DNA methylation of CDH13, TFPI2, and FSTL1 in squamous cell carcinoma of the esophagus in vivo. Anti-Cancer Drugs. 2016;27(9):848–853. doi: 10.1097/CAD.0000000000000396. PubMed DOI
Bae K., Park K. E., Han J., Kim J., Kim K., Yoon K.-A. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk 1/2 in human lung cancer cells. Oncotarget. 2016;7(14):18076–18084. doi: 10.18632/oncotarget.6729. PubMed DOI PMC
Liang X., Hu Q., Li B., et al. Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats. Stroke. 2014;45(10):3048–3054. doi: 10.1161/STROKEAHA.114.006092. PubMed DOI PMC
Ouchi N., Oshima Y., Ohashi K., et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. The Journal of Biological Chemistry. 2008;283(47):32802–32811. doi: 10.1074/jbc.M803440200. PubMed DOI PMC
Waldera Lupa D. M., Kalfalah F., Safferling K., et al. Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. The Journal of Investigative Dermatology. 2015;135(8):1954–1968. doi: 10.1038/jid.2015.120. PubMed DOI
Yang W., Wu Y., Wang C., Liu Z., Xu M., Zheng X. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β—dependent manner in hepatocellular carcinoma. Cancer Biomarkers. 2017;20(1):75–85. doi: 10.3233/CBM-170132. PubMed DOI
Chen W., Xia J., Hu P., et al. Follistatin-like 1 protects cardiomyoblasts from injury induced by sodium nitroprusside through modulating Akt and Smad1/5/9 signaling. Biochemical and Biophysical Research Communications. 2016;469(3):418–423. doi: 10.1016/j.bbrc.2015.12.026. PubMed DOI
Wu J., Dong Y., Teng X., Cheng M., Shen Z., Chen W. Follistatin-like 1 attenuates differentiation and survival of erythroid cells through Smad2/3 signaling. Biochemical and Biophysical Research Communications. 2015;466(4):711–716. doi: 10.1016/j.bbrc.2015.09.044. PubMed DOI
Alkhouri N., Gornicka A., Berk M. P., et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. The Journal of Biological Chemistry. 2010;285(5):3428–3438. doi: 10.1074/jbc.M109.074252. PubMed DOI PMC
Clutter S. D., Wilson D. C., Marinov A. D., Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-γ . The Journal of Immunology. 2008;182(1):234–239. doi: 10.4049/jimmunol.182.1.234. PubMed DOI PMC
Li D., Wang Y., Xu N., et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Research & Therapy. 2011;13(1):p. R17. doi: 10.1186/ar3241. PubMed DOI PMC
le Luduec J. B., Condamine T., Louvet C., et al. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. American Journal of Transplantation. 2008;8(11):2297–2306. doi: 10.1111/j.1600-6143.2008.02398.x. PubMed DOI
Tchkonia T., Morbeck D. E., von Zglinicki T., et al. Fat tissue, aging, and cellular senescence. Aging Cell. 2010;9(5):667–684. doi: 10.1111/j.1474-9726.2010.00608.x. PubMed DOI PMC
Yoo J. K., Choi S., Kim J. K. Expression profiles of subtracted mRNAs during cellular senescence in human mesenchymal stem cells derived from bone marrow. Experimental Gerontology. 2013;48(5):464–471. doi: 10.1016/j.exger.2013.02.022. PubMed DOI
Wang Y., Li D., Xu N., et al. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis. Arthritis Research & Therapy. 2011;13(6):p. R193. doi: 10.1186/ar3522. PubMed DOI PMC
Iacomino G., Russo P., Stillitano I., et al. Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I. Family study. Genes & Nutrition. 2016;11(1):p. 7. doi: 10.1186/s12263-016-0525-3. PubMed DOI PMC
Görgens S. W., Raschke S., Holven K. B., Jensen J., Eckardt K., Eckel J. Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells. Archives of Physiology and Biochemistry. 2013;119(2):75–80. doi: 10.3109/13813455.2013.768270. PubMed DOI